Berberine

What it does

Berberine is a plant alkaloid traditionally used in Chinese medicine. It activates AMPK, an energy-sensing pathway, which is why it gets compared to metformin and studied for blood sugar and lipids.

What the research says

• May lower blood glucose and HbA1c

  Evidence: moderate. Many trials, mostly small and short, show glucose-lowering effects comparable in direction to metformin, with quality concerns. Needs verification.

• May improve lipid profiles

  Evidence: moderate. Trials report reductions in LDL and triglycerides; same quality caveats as the glucose data. Needs verification.

DRAFT: consistent direction across many trials, but most are small, short, or from single research groups; a large high-quality trial would move this.

What the experts say

Every position links to its source. We include skeptics alongside supporters.

• Peter Attia

  “It's a poor man's version of metformin. I don't find that that interesting. I prefer to just use metformin.”

  Source Calls berberine a weak AMPK activator and a poor man's version of metformin, saying he is unimpressed and prefers metformin for its consistency and regulation; he does still use berberine clinically for its weak PCSK9 inhibition in patients with high LDL from defective clearance.

• Andrew Huberman

  “If I took berberine and I did not ingest a profound number of carbohydrates very soon afterwards, I got brutal headaches. I think I was hypoglycemic.”

  Source Recounts a personal trial where berberine blunted blood sugar spikes from heavy carb intake, but notes he got brutal headaches when he took it without a large carbohydrate load soon after, suggesting hypoglycemia.

Is it worth it?

DRAFT: cheap with a consistent metabolic signal; drug interactions are the main reason for caution, not cost.